|
| 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide Basic information |
| 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide Chemical Properties |
Boiling point | 622.8±55.0 °C(Predicted) | density | 1.41±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 100 mg/mL (273.37 mM; Need ultrasonic) | form | Powder | pka | 16.07±0.40(Predicted) | color | White to off-white |
| 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide Usage And Synthesis |
Uses | BET Bromodomain Inhibitor has be shown to inhibit myeloma cell proliferation in clinically relevant models. |
| 2-[6-(4-Chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide Preparation Products And Raw materials |
|